Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The Right to Override Act requires covered entities that use artificial intelligence clinical decision support systems (AI/CDSS) to adopt policies ensuring AI outputs do not replace a health care professional’s independent judgment and to permit timely clinician overrides when appropriate. It mandates training, worker input (including an AI/CDSS committee with non-manager and labor representation), restrictions on sharing override data that identify clinicians, and mechanisms for reviewing AI performance and feedback.
Scope and cost: liberals emphasize worker and patient protections; conservatives emphasize regulatory cost and litigation risk.
Relative to its intended legislative type, this bill is a clearly focused substantive statute that creates new rights and obligations concerning the use of AI/CDSS in health care, sets out enforcement pathways, and integrates with existing law.
The Right to Override Act requires covered entities that use artificial intelligence clinical decision support systems (AI/CDSS) to adopt policies ensuring AI outputs do not replace a health care professional’s independent judgment and to permit timely clinician overrides when appropriate.
It mandates training, worker input (including an AI/CDSS committee with non-manager and labor representation), restrictions on sharing override data that identify clinicians, and mechanisms for reviewing AI performance and feedback.
The Act prohibits adverse employment actions and retaliation against clinicians who override AI/CDSS outputs consistent with the law, establishes whistleblower protections, and creates enforcement pathways through the Departments of Health and Human Services (Office for Civil Rights) and Labor, including civil penalties and a private right of action.
On content alone, the bill addresses widely recognized concerns about AI in health care and clinician autonomy—features that can attract bipartisan interest—but contains several provisions (broad private right of action with treble damages, ban on predispute arbitration, robust whistleblower remedies, and notable compliance/liability burdens) that tend to mobilize organized opposition from healthcare providers, insurers, and tech vendors. The procedural complexity (dual enforcement by HHS and DOL, interaction with state law and federal funding) and lack of built-in phased testing or targeted pilot approaches make it more likely the bill would be amended heavily or folded into a larger, negotiated package rather than pass as drafted.
Relative to its intended legislative type, this bill is a clearly focused substantive statute that creates new rights and obligations concerning the use of AI/CDSS in health care, sets out enforcement pathways, and integrates with existing law. Its core mechanisms, enforcement authorities, and definitional framework are well articulated.
Scope and cost: liberals emphasize worker and patient protections; conservatives emphasize regulatory cost and litigation risk.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope and cost: liberals emphasize worker and patient protections; conservatives emphasize regulatory cost and litigation risk.
A mainstream progressive would likely view this bill positively as a worker- and patient-protecting measure that guards clinician judgment, reduces algorithmic bias, and strengthens whistleblower protections.
It emphasizes training, worker input, and limits on employer use of individual override data — aspects that align with protecting frontline staff and preventing punitive use of AI metrics.
The persona would appreciate the ban on arbitration and the private right of action as tools to hold employers accountable.
A moderate would generally approve of protections for clinician judgment and whistleblower safeguards but will weigh them against burdens on providers and potential legal exposure.
They would appreciate the procedural elements (committees, training, HHS/DOL oversight) as reasonable governance, while seeking clearer standards for when an override is “appropriate” and better calibration of penalties.
The centrist will want to ensure the bill does not unduly impede legitimate employer oversight of quality or create perverse incentives to override without clinical basis.
A mainstream conservative would be skeptical, seeing the bill as federal overreach into employer management, increasing regulatory burdens and litigation risk.
They would be concerned that prohibitions on sharing clinician-specific override data, the ban on predispute arbitration, and the availability of treble and statutory damages expand employer liability and undermine efficient dispute resolution.
The persona would also worry the law could reduce incentives for employers to use validated AI/CDSS or to monitor poor-performing clinicians, potentially risking patient safety and operational efficiency.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill addresses widely recognized concerns about AI in health care and clinician autonomy—features that can attract bipartisan interest—but contains several provisions (broad private right of action with treble damages, ban on predispute arbitration, robust whistleblower remedies, and notable compliance/liability burdens) that tend to mobilize organized opposition from healthcare providers, insurers, and tech vendors. The procedural complexity (dual enforcement by HHS and DOL, interaction with state law and federal funding) and lack of built-in phased testing or targeted pilot approaches make it more likely the bill would be amended heavily or folded into a larger, negotiated package rather than pass as drafted.
The bill has not accumulated any surfaced votes yet.
Scope and cost: liberals emphasize worker and patient protections; conservatives emphasize regulatory cost and litigation risk.
On content alone, the bill addresses widely recognized concerns about AI in health care and clinician autonomy—features that can attract bi…
Relative to its intended legislative type, this bill is a clearly focused substantive statute that creates new rights and obligations concerning the use of AI/CDSS in health care, sets out enforcement pathways, and inte…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.